No Data
No Data
Morgan Stanley Maintains R1 RCM(RCM.US) With Hold Rating, Maintains Target Price $14.3
Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Disc Medicine (IRON) and R1 RCM (RCM)
Express News | R1 RCM Inc: Preliminary Q3 Net Service Revenue $643.0 Mln-$658.0 Mln
Banks Launch $3.3 Billion Loan Package for R1 RCM's Buyout
Is R1 RCM Inc. (NASDAQ:RCM) The Best NASDAQ Stock Under $20?
R1 RCM Announces Merger and Demonstrates Financial Growth
No Data
No Data